Announcements Trials
Browse Landscape

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 48OTHER_GOV 3INDUSTRY 3

Study Type

Interventional 19Observational 3

Sponsor

Conditions

Breast Neoplasms 467Neoplasms 315Carcinoma, Non-Small-Cell Lung 269Prostatic Neoplasms 215Colorectal Neoplasms 207Lung Neoplasms 176Multiple Myeloma 123Melanoma 110Carcinoma, Renal Cell 107Ovarian Neoplasms 94Carcinoma, Hepatocellular 78Pancreatic Neoplasms 69Urinary Bladder Neoplasms 65Stomach Neoplasms 64Neoplasm Metastasis 64Leukemia, Lymphocytic, Chronic, B-Cell 62Colonic Neoplasms 59Leukemia, Myeloid, Acute 53Uterine Cervical Neoplasms 50Recurrence 49Liver Neoplasms 46Lymphoma, Follicular 45Lymphoma 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39Esophageal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Large B-Cell, Diffuse 35Hematologic Neoplasms 35Head and Neck Neoplasms 35Lymphoma, Non-Hodgkin 34

Interventions

ziconotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Chronic Pain × Clear all
NCT06541184 2025-02-27

Ziconotide for Non-cancer Pain by Intrathecal Administration

ESTEVE Pharmaceuticals SAS

Recruiting
85 enrolled

Chronic Pain

NCT04287075 2024-03-26

Rethink Pain

Axogen Corporation

Terminated
8 enrolled

Neuralgia, Neuroma, Peripheral Nervous System Diseases, Peripheral Nerve Injuries, Chronic Pain

NCT01688583 2013-11-21

The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement

Janssen Korea, Ltd., Korea

Completed
410 enrolled

Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡